Velicept Investigative Site - Lincoln — Lincoln, Rhode Island

Velicept Investigative Site - Lincoln is a clinical research site located in Lincoln, Rhode Island, United States 02865.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Velicept Investigative Site - Lincoln has participated in 1 clinical trials.

Therapeutic areas: Overactive Bladder.

Sponsors: Velicept Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lincoln

Browse all research sites in Rhode Island · View every site in Lincoln

• Lincoln Research
• Research Site
• Ocean State Clinical Research Partners
• GSK Investigational Site
• Pfizer Investigational Site
• BTC of Lincoln
• Novartis Investigative Site
• AAPRI Clinical Research Institute
• Forest Investigative Site 059
• Alkermes Investigational Site
• Ocean St Clin Res Partnrs, LLC
• Forest Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velicept Investigative Site - Lincoln?

Velicept Investigative Site - Lincoln has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velicept Investigative Site - Lincoln conducted?

Velicept Investigative Site - Lincoln has 1 clinical trials on record. Their work covers Overactive Bladder.

Is Velicept Investigative Site - Lincoln accredited by Crixeo Clinical Trials?

Velicept Investigative Site - Lincoln has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velicept Investigative Site - Lincoln?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.